CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 15, 2006--Altus Pharmaceuticals Inc. (Nasdaq: ALTU - News), a biopharmaceutical company focused on the development and commercialization of oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders, today reported financial results for the first three months ended March 31, 2006.
